Schedule 13D ownership disclosure

LOXO ONCOLOGY INC

Security class unavailable · CUSIP: 548862101

Event date: 2016-08-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.9800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-16-001414
Form type
SC 13D/A
Filer
Loxo Oncology, Inc.
CIK
CIK 1581720
Filed
Aug 12, 2016
Reporting period
Aug 10, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub